167 related articles for article (PubMed ID: 27349790)
1. Novel high/low solubility classification methods for new molecular entities.
Dave RA; Morris ME
Int J Pharm; 2016 Sep; 511(1):111-126. PubMed ID: 27349790
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
3. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
4. BDDCS class prediction for new molecular entities.
Broccatelli F; Cruciani G; Benet LZ; Oprea TI
Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
[TBL] [Abstract][Full Text] [Related]
5. Is the full potential of the biopharmaceutics classification system reached?
Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
[TBL] [Abstract][Full Text] [Related]
6. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver.
Plöger GF; Hofsäss MA; Dressman JB
J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
8. BDDCS applied to over 900 drugs.
Benet LZ; Broccatelli F; Oprea TI
AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
[TBL] [Abstract][Full Text] [Related]
9. Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): theoretical basis and practical examples.
Papadopoulou V; Valsami G; Dokoumetzidis A; Macheras P
Int J Pharm; 2008 Sep; 361(1-2):70-7. PubMed ID: 18614303
[TBL] [Abstract][Full Text] [Related]
10. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.
Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL
Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
Golfar Y; Shayanfar A
J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
[TBL] [Abstract][Full Text] [Related]
12. Provisional biopharmaceutical classification of some common herbs used in Western medicine.
Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R
Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942
[TBL] [Abstract][Full Text] [Related]
13. Computational models to assign biopharmaceutics drug disposition classification from molecular structure.
Khandelwal A; Bahadduri PM; Chang C; Polli JE; Swaan PW; Ekins S
Pharm Res; 2007 Dec; 24(12):2249-62. PubMed ID: 17846869
[TBL] [Abstract][Full Text] [Related]
14. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
Benet LZ
J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
[TBL] [Abstract][Full Text] [Related]
15. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
Bocci G; Oprea TI; Benet LZ
AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
[TBL] [Abstract][Full Text] [Related]
16. A non-binary biopharmaceutical classification of drugs: the ABΓ system.
Macheras P; Karalis V
Int J Pharm; 2014 Apr; 464(1-2):85-90. PubMed ID: 24456673
[TBL] [Abstract][Full Text] [Related]
17. Purely in silico BCS classification: science based quality standards for the world's drugs.
Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL
Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040
[TBL] [Abstract][Full Text] [Related]
18. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
Hosey CM; Chan R; Benet LZ
AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS).
Fagerholm U
J Pharm Pharmacol; 2007 Jun; 59(6):751-7. PubMed ID: 17637167
[TBL] [Abstract][Full Text] [Related]
20. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
Li J; Larregieu CA; Benet LZ
Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
